AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21113641 — intervention group
Group type: EXPERIMENTAL
Intervention: rTSMS (10 Hz, 100% intensity of stimulator output, n=14)
Number of subjects: 23
Study 21113641 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (n=13)
Number of subjects: 23
Study 21113641 — intervention group
Group type: EXPERIMENTAL
Intervention: rTSMS
Number of subjects: 23
Study 21113641 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study 19175617 — intervention group
Group type: EXPERIMENTAL
Intervention: High permeability haemodialysis (HPHD)
Number of subjects: 116
Study 19175617 — intervention group
Group type: COMPARATOR
Intervention: Conventional haemodialysis (CHD)
Number of subjects: 116
Study 18036080 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg) administered every 2 hours each night for 4 administrations
Number of subjects: 23
Study 18036080 — intervention group
Group type: COMPARATOR
Intervention: No caffeine (control group)
Number of subjects: 23
Study 15169748 — intervention group
Group type: EXPERIMENTAL
Intervention: Surprise hard surface (411 kN/m)
Number of subjects: 0
Study 15169748 — intervention group
Group type: COMPARATOR
Intervention: Expected hard surface (411 kN/m)
Number of subjects: 0
Study 15169748 — intervention group
Group type: COMPARATOR
Intervention: Random hard surface (411 kN/m)
Number of subjects: 0
Study 11320608 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized hemicraniectomy and duraplasty
Number of subjects: 92
Study 11320608 — intervention group
Group type: COMPARATOR
Intervention: Traditional craniotomy (with brain amputation at the neurosurgeon's discretion)
Number of subjects: 92
Study 9462190 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume controlled ventilation
Number of subjects: 50
Study 9462190 — intervention group
Group type: COMPARATOR
Intervention: Time cycled, pressure limited ventilation
Number of subjects: 50
Study 8203435 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative gonadotropin-releasing hormone agonist (leuprolide acetate) for 2 months
Number of subjects: 150
Study 8203435 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative gonadotropin-releasing hormone agonist (leuprolide acetate)
Number of subjects: 150
Study 3115283 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil
Number of subjects: 44
Study 3115283 — intervention group
Group type: COMPARATOR
Intervention: halothane
Number of subjects: 44
Study 31944420 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia implants
Number of subjects: 22
Study 31944420 — intervention group
Group type: COMPARATOR
Intervention: Titanium implants
Number of subjects: 22
Study 29203473 — intervention group
Group type: EXPERIMENTAL
Intervention: THR‐184 treatment groups
Number of subjects: 452
Study 29203473 — intervention group
Group type: COMPARATOR
Intervention: Placebo groups
Number of subjects: 452
Study 28824757 — intervention group
Group type: EXPERIMENTAL
Intervention: WOOP
Number of subjects: 34
Study 28824757 — intervention group
Group type: COMPARATOR
Intervention: Goal Setting
Number of subjects: 34
Study 25760511 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic fields
Number of subjects: 66
Study 25760511 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 66
Study 22966852 — intervention group
Group type: EXPERIMENTAL
Intervention: Long LVLED (LVLED ≥ 50% of QRS)
Number of subjects: 31
Study 22966852 — intervention group
Group type: COMPARATOR
Intervention: Short LVLED (LVLED < 50%)
Number of subjects: 31
Study 22966852 — intervention group
Group type: EXPERIMENTAL
Intervention: Long LVLED
Number of subjects: 31
Study 22966852 — intervention group
Group type: COMPARATOR
Intervention: Short LVLED
Number of subjects: 31
Study 20556561 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 600 mg + Hydrochlorothiazide 12.5 mg
Number of subjects: 155
Study 20556561 — intervention group
Group type: COMPARATOR
Intervention: Losartan 50 mg + Hydrochlorothiazide 12.5 mg
Number of subjects: 155
Study 18277347 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound (TV ultrasound) using the Toshiba JustVision 400 system at the end of the surgical procedure.
Number of subjects: 720
Study 18277347 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ultrasound examination at the end of surgery).
Number of subjects: 720
Study 15842137 — intervention group
Group type: EXPERIMENTAL
Intervention: Jianpi Huoxue herbs (JPHXH) plus chemotherapy (CT)
Number of subjects: 64
Study 15842137 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (CT) alone
Number of subjects: 64
Study 12740051 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fibre intake
Number of subjects: 4080
Study 10229292 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 3250
Study 10229292 — intervention group
Group type: EXPERIMENTAL
Intervention: Single drug therapy (most commonly an ACE inhibitor)
Number of subjects: 3250
Study 8708070 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast medium injected over 30 s (Group A)
Number of subjects: 119
Study 8708070 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast medium injected over 45 s (Group B)
Number of subjects: 119
Study 8708070 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast medium injected over 60 s (Group C)
Number of subjects: 119
Study 1751272 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg kg‐1 followed by fentanyl 2 micrograms kg‐1
Number of subjects: 12
Study 1751272 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 12
Study 6936524 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocodone-acetaminophen combination
Number of subjects: 0
Study 6936524 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine-acetaminophen combination
Number of subjects: 0
Study 6936524 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine-APC combination
Number of subjects: 0
Study 6936524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31583824 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive restructuring intervention 'Michael's game'
Number of subjects: 172
Study 31583824 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 172
Study 31150729 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.14% potassium oxalate strip
Number of subjects: 80
Study 31150729 — intervention group
Group type: COMPARATOR
Intervention: 8% arginine calcium carbonate toothpaste (control)
Number of subjects: 80
Study 28024265 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental supportive care approach (psychosocial nurse referral to healthcare providers)
Number of subjects: 223
Study 28024265 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 223
Study 28024265 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental supportive care approach
Number of subjects: 223
Study 25913937 — intervention group
Group type: EXPERIMENTAL
Intervention: 1MIN‐HIIT
Number of subjects: 25
Study 25913937 — intervention group
Group type: EXPERIMENTAL
Intervention: 2MIN‐HIIT
Number of subjects: 25
Study 25913937 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 25
Study 23357431 — intervention group
Group type: EXPERIMENTAL
Intervention: High-energy variant of soup (HE spinach)
Number of subjects: 40
Study 23357431 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy variant of soup (LE endive)
Number of subjects: 40
Study 23357431 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable soup consistently paired with high energy
Number of subjects: 40
Study 23357431 — intervention group
Group type: COMPARATOR
Intervention: Vegetable soup consistently paired with low energy
Number of subjects: 40
Study 21377930 — intervention group
Group type: EXPERIMENTAL
Intervention: Zalutumumab plus best supportive care
Number of subjects: 286
Study 21377930 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (control group)
Number of subjects: 286
Study 19541918 — intervention group
Group type: COMPARATOR
Intervention: Individualized best conventional therapy (CONV)
Number of subjects: 148
Study 19541918 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized impairment-oriented training (IOT)
Number of subjects: 148
Study 17578986 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral glossopharyngeal nerve block with 0.75% ropivacaine with epinephrine (Group R)
Number of subjects: 75
Study 17578986 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral glossopharyngeal nerve block with 0.5% bupivacaine with epinephrine (Group B)
Number of subjects: 75
Study 17578986 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Group C)
Number of subjects: 75
Study 14988688 — intervention group
Group type: EXPERIMENTAL
Intervention: Potent, selective inhibitor of type I 5 alpha-reductase used alone
Number of subjects: 0
Study 14988688 — intervention group
Group type: EXPERIMENTAL
Intervention: Potent, selective inhibitor of type I 5 alpha-reductase in combination with systemic minocycline
Number of subjects: 0
Study 14988688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11377310 — intervention group
Group type: COMPARATOR
Intervention: Room temperature irrigation fluid (70 degrees F)
Number of subjects: 56
Study 11377310 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed irrigation fluid (91.5 degrees F)
Number of subjects: 56
Study 10211015 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia with bupivacaine (40 mg bolus followed by 15 mg h‐1 infusion)
Number of subjects: 20
Study 10211015 — intervention group
Group type: COMPARATOR
Intervention: Control group (no epidural analgesia)
Number of subjects: 20
Study 8155447 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 16
Study 8155447 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin (NTG)
Number of subjects: 16
Study 2842146 — intervention group
Group type: EXPERIMENTAL
Intervention: Leguminous meal
Number of subjects: 25
Study 2842146 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed dietary fibre meal
Number of subjects: 25
Study 2842146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cereal meal
Number of subjects: 25
Study 2842146 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fibre test meals
Number of subjects: 25
Study 2842146 — intervention group
Group type: EXPERIMENTAL
Intervention: All meals
Number of subjects: 25
Study 29861139 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 1713
Study 29861139 — intervention group
Group type: EXPERIMENTAL
Intervention: Endarterectomy
Number of subjects: 1713
Study 29861139 — intervention group
Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 1713
Study 28243467 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium ranelate (not detailed in the abstract)
Number of subjects: 869
Study 28243467 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 869
Study 26571884 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and medication group (acupuncture + 20 mg fluoxetine once daily for 4 weeks)
Number of subjects: 63
Study 26571884 — intervention group
Group type: COMPARATOR
Intervention: Medication group (20 mg fluoxetine once daily for 4 weeks)
Number of subjects: 63
Study 23045995 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered health education (THE)
Number of subjects: 71
Study 23045995 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered interpersonal counselling (TIP-C)
Number of subjects: 71
Study 21037250 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent myocardial infarction (MI)
Number of subjects: 10599
Study 21037250 — intervention group
Group type: EXPERIMENTAL
Intervention: Early reinfarctions (within 1 month)
Number of subjects: 10599
Study 17851980 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased mentally stimulating activities for 10-12 weeks
Number of subjects: 44
Study 17851980 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 44
Study 17146419 — intervention group
Group type: EXPERIMENTAL
Intervention: food supplement containing hydrolyzed sea fish cartilage, vitamin C, vitamin E, folic acid, zinc, copper (Captafer)
Number of subjects: 49
Study 17146419 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 49
Study 17146419 — intervention group
Group type: EXPERIMENTAL
Intervention: food supplement
Number of subjects: 49
Study 14725385 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing 2% zinc citrate and 0.3% Triclosan
Number of subjects: 0
Study 14725385 — intervention group
Group type: COMPARATOR
Intervention: Toothpaste containing 0.3% Triclosan and 2% copolymer
Number of subjects: 0
Study 10811549 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 100 mg
Number of subjects: 15
Study 10811549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 8604913 — intervention group
Group type: EXPERIMENTAL
Intervention: FOSL-HN (fish oil/medium-chain triglyceride structured lipid)
Number of subjects: 50
Study 8604913 — intervention group
Group type: COMPARATOR
Intervention: O-HN (isonitrogenous, isocaloric formula)
Number of subjects: 50
Study 1582107 — intervention group
Group type: COMPARATOR
Intervention: Conventional ibuprofen tablets 600 mg QID (CI)
Number of subjects: 147
Study 1582107 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release ibuprofen tablets 1200 mg BID (SRI)
Number of subjects: 147
Study 1582107 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 147
Study 3973309 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral food challenge with suspected food
Number of subjects: 45
Study 3973309 — intervention group
Group type: COMPARATOR
Intervention: History of allergic reactions
Number of subjects: 45
Study 3973309 — intervention group
Group type: COMPARATOR
Intervention: Reaction patterns reported by history
Number of subjects: 45
Study 3973309 — intervention group
Group type: COMPARATOR
Intervention: Complete blood count with differential, blood chemistries, and serum immunoglobulin levels
Number of subjects: 45
Study 31481571 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 200
Study 31481571 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 200
Study 31481571 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 200
Study 27369044 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-weekly emails for first 4 weeks and then weekly emails for the next 8 weeks targeting self‐efficacy, social support, goal setting, and benefits/barriers to walking (Dog owners)
Number of subjects: 105
Study 27369044 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-weekly emails for first 4 weeks and then weekly emails for the next 8 weeks targeting self‐efficacy, social support, goal setting, and benefits/barriers to walking (Non-dog owners)
Number of subjects: 105
Study 27369044 — intervention group
Group type: COMPARATOR
Intervention: 1-time email reviewing current physical activity guidelines (Control group)
Number of subjects: 105
Study 26275164 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean mindfulness-based stress reduction (K‐MBSR)
Number of subjects: 56
Study 26275164 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 56
Study 26275164 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education
Number of subjects: 56
Study 26275164 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 56
Study 23800154 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily dietary supplementation with Creatine 340 mg + 320 mg Coenzyme Q‐Ter for 2 months (Group A)
Number of subjects: 55
Study 23800154 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group B)
Number of subjects: 55
Study 21555764 — intervention group
Group type: EXPERIMENTAL
Intervention: Etravirine (ETR) 200 mg q12h
Number of subjects: 0
Study 21555764 — intervention group
Group type: EXPERIMENTAL
Intervention: Etravirine (ETR) combined with Lopinavir (LPV)/Ritonavir (RTV) 200/400/100 mg q12h
Number of subjects: 0
Study 21555764 — intervention group
Group type: EXPERIMENTAL
Intervention: Etravirine (ETR) combined with Darunavir (DRV)/Ritonavir (RTV) 200/600/100 mg q12h
Number of subjects: 0
Study 19327739 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative sub-Tenon injection of triamcinolone acetonide (TA)
Number of subjects: 53
Study 19327739 — intervention group
Group type: COMPARATOR
Intervention: No intraoperative sub-Tenon injection of triamcinolone acetonide (TA)
Number of subjects: 53
Study 19327739 — intervention group
Group type: COMPARATOR
Intervention: Both groups (TA and control)
Number of subjects: 53
Study 17576909 — intervention group
Group type: COMPARATOR
Intervention: Steroids
Number of subjects: 20
Study 17576909 — intervention group
Group type: COMPARATOR
Intervention: Antiviral plus steroid therapy
Number of subjects: 20
Study 14718426 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol
Number of subjects: 88
Study 14718426 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 88
Study 12053495 — intervention group
Group type: EXPERIMENTAL
Intervention: Triage angiography within 6 hours of symptom onset
Number of subjects: 201
Study 12053495 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical care
Number of subjects: 201
Study 9556926 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of antibodies against Trypanosoma cruzi using a commercial ELISA kit
Number of subjects: 318
Study 9556926 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated blood donation
Number of subjects: 318
Study 8052870 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin/etoposide chemotherapy and thoracic irradiation
Number of subjects: 0
Study 8052870 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin/etoposide chemotherapy and thoracic irradiation
Number of subjects: 0
Study 8052870 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic irradiation
Number of subjects: 0
Study 8052870 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic brain irradiation
Number of subjects: 0
Study 3396492 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin 2g
Number of subjects: 40
Study 3396492 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime 2g
Number of subjects: 40
Study 31177755 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminium content in wheat
Number of subjects: 454
Study 31177755 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminium content in soybean
Number of subjects: 454
Study 31177755 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminium content in corn
Number of subjects: 454
Study 31177755 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminium content in rice
Number of subjects: 454
Study 31177755 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminium content in millet
Number of subjects: 454
Study 31177755 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper bound values of 95%CI of P(99) of aluminium contents
Number of subjects: 454
Study 28870191 — intervention group
Group type: EXPERIMENTAL
Intervention: Translatory dorsal glide mobilization (TDGM) C0‐C1 technique, adjunct to protocolized physiotherapy treatment
Number of subjects: 78
Study 28870191 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure maintained suboccipital inhibition technique (PMSIT), adjunct to protocolized physiotherapy treatment
Number of subjects: 78
Study 28870191 — intervention group
Group type: COMPARATOR
Intervention: Protocolized treatment (Control Group)
Number of subjects: 78
Study 26004142 — intervention group
Group type: COMPARATOR
Intervention: CCBT
Number of subjects: 211
Study 26004142 — intervention group
Group type: EXPERIMENTAL
Intervention: CCBT + MCBT
Number of subjects: 211
Study 26004142 — intervention group
Group type: EXPERIMENTAL
Intervention: CCBT + MCI
Number of subjects: 211
Study 22978325 — intervention group
Group type: EXPERIMENTAL
Intervention: Music-movement therapy (60 minutes, three times per week for 8 weeks)
Number of subjects: 0
Study 22978325 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 0
Study 22101378 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral valganciclovir (VGCV) 900 mg/day
Number of subjects: 22
Study 22101378 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ganciclovir (GCV) 5 mg/kg twice daily
Number of subjects: 22
Study 18207117 — intervention group
Group type: EXPERIMENTAL
Intervention: Speeded detection task with audiovisual displays
Number of subjects: 0
Study 18207117 — intervention group
Group type: EXPERIMENTAL
Intervention: Speeded modality discrimination task with audiovisual displays
Number of subjects: 0
Study 18207117 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant task with visual targets
Number of subjects: 0
Study 18207117 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant task with auditory targets
Number of subjects: 0
Study 16436892 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired hemodiafiltration (PHF)
Number of subjects: 12
Study 16436892 — intervention group
Group type: COMPARATOR
Intervention: Standard dialysis (bicarbonate dialysis)
Number of subjects: 12
Study 14604204 — intervention group
Group type: EXPERIMENTAL
Intervention: Flush before fill
Number of subjects: 121
Study 14604204 — intervention group
Group type: COMPARATOR
Intervention: No flush
Number of subjects: 121
Study 14604204 — intervention group
Group type: EXPERIMENTAL
Intervention: Flush before fill (females)
Number of subjects: 121
Study 14604204 — intervention group
Group type: COMPARATOR
Intervention: No flush (females)
Number of subjects: 121
Study 10790839 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma education space adventure game (Air Academy: The Quest for Airtopia)
Number of subjects: 0
Study 10790839 — intervention group
Group type: COMPARATOR
Intervention: Control classroom (no computer game)
Number of subjects: 0
Study 10790839 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-led talks (additional intervention)
Number of subjects: 0
Study 9392919 — intervention group
Group type: EXPERIMENTAL
Intervention: Exam A
Number of subjects: 78
Study 9392919 — intervention group
Group type: EXPERIMENTAL
Intervention: Exam B
Number of subjects: 78
Study 9392919 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Exams A and B
Number of subjects: 78
Study 9392919 — intervention group
Group type: COMPARATOR
Intervention: Urinary catheterization
Number of subjects: 78